Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
20,000 participants in 5 patient groups
Loading...
Central trial contact
Casey MacDermod, BA; Laura M Thornton, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal